Maiwald Magazine

News and Releases

Maiwald Blog

No Interruption of Forfeiture Periods in the Event of Negligent Legal Action

In a recent judgment, the ECJ has now clarified under which conditions a cease and desist letter can interrupt forfeiture periods (ECJ GRUR 2022, 986 - HEITEC.). Accor...

Continue reading

News from Brussels – Stricter rules on pesticides and human substances for medical treatments & therapies

In the past few weeks the EU Commission made several legislative proposals in the areas of chemistry/food safety and safety of (medical) products. Two of those topics we would...

Continue reading

Free samples of medicinal products to pharmacists – Section 7 (1) Health Services and Products Advertising Act (HWG) 

Higher Regional Court, Frankfurt am Main, judgment dated 10 February 2022, Case No. 6 U 161/15 As reported here on

Continue reading

All articles

Press Coverage

Royalty Pharma agrees to acquire Royalty Interest in Trelegy Ellipta from Theravance and Innoviva for $1.31 Billion and potential Milestones of $300 Million

• Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy• Expected to significantly add to long-term Adjusted Cash Receipts growth (non-GAAP) NEW YORK, NY,...

Continue reading

Royalty Pharma acquires Royalty interest in Gavreto from Blueprint medicines for up to $340 Million

Attractive, precision oncology therapy with long patent duration added to portfolioBlueprint Medicines to receive $175 million upfront and $165 million in potential milestone payments

Continue reading

Bayer withdraws second PI in Nexavar battle against generic drug manufacturers

Stada, Zentiva and four other generic drug companies can launch their generic products after Bayer withdrew its second application for a preliminary injunction to protect its cancer drug, Nexavar. But the companies could still face a costly damages claim if the court ultimat...

Continue reading

Maiwald in the press

Staff News

Maiwald appoints Dr Gisela Grabow as Counsel/ Tobias Matschke becomes Principal

With effect from 1 July 2022, Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH, one of Germany's leading law firms in the field of intellectual property protection, ha...

Continue reading

Maiwald Congratulates on Passing the EQE Examination

We are very pleased to congratulate Dr Felix Schröter, Dr ...

Continue reading

Dr Ulrike Herr takes up role as partner with Maiwald

Patent attorney Dr Ulrike Herr joins Maiwald as...

Continue reading

All Staff News

Publications

Germany cancels agreement with Switzerland on the use of trademarks, 2022

In the September edition of Managing Intellectual Property Susanna Heurung

Continue reading

Ergänzende Schutzzertifikate – Überblick und Ausblick zur EU-Initiative, Arzneimittel & Recht, 2022

SPCs are currently based on Regulation (EC) No. 469/2009 on the supplementary protection certificate for medicinal products. Under a current EU initiative, the Commission is p...

Continue reading

All publications

Awards

FOCUS List of Top Commercial Law Firms in Germany 2022

This year, FOCUS presented Germany's top commercial law firms for the tenth time in a row. We are delighted that we were able to convince and belong to the top commercial law ...

Continue reading

IAM Strategy 300 2022

IAM recommends six of our partners again this year, Dr Eva Dörner, 

Continue reading

Who’s Who Legal 2022

Dr Marco

Continue reading

All awards

Events

Maiwald @ APAA 2022 in South Korea

The 73rd council meeting of the Asian Patent Attorneys Association (APAA 2022) will take place in Busan from October 15 to 18. Maiwald will be represented on site by Dr Berthold Lux, Angela Zumstein and

Continue reading

Maiwald Hiking Day 2022

This year’s company excursion took us on a relaxed hike around Lake Tegernsee in the direction of Gut Kaltenbrunn. Regardless of whether it was a short hiking route or an extended tour, in the end we all arrived at the meeting point to enjoy the afternoon together. Due to excellent food, great music and good mood, the day was a complete success.

Continue reading

All events